InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（3 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
3
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by Goodman Vicki L, Directrice Générale du Développement de Produits. Officer active across 2 companies, notably Exelixis, INC.. Cumulatively, 9 reports have been logged. Split: 0 buy · 3 sells. Total volume traded: €74k. Activity tracked since 4 January 2022. The latest transaction was disclosed on 10 November 2025 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Goodman Vicki L
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报9 总计
84,727 股Ordinary SharesSEC:0001193125-25-308745:0
5,036 股@ US$2.0812.3% 占其流量Ordinary SharesSEC:0001193125-25-274765:0
35,000 股0Ordinary SharesSEC:0000950170-25-033764:0
13,186 股@ US$3.8975.7% 占其流量Ordinary SharesSEC:0000950170-25-026609:0
5,069 股@ US$3.3324.3% 占其流量Ordinary SharesSEC:0000950170-24-124041:0
73,018 股0Ordinary SharesSEC:0000950170-23-071113:0
82,566 股0Common StockSEC:0000939767-23-000037:0
17,299 股@ US$18.08100.0% 占其流量Common StockSEC:0000939767-23-000022:0
250,000 股0Common StockSEC:0000939767-22-000004:0
9 条申报中的 9 条
About Goodman Vicki L
Goodman Vicki L is Directrice Générale du Développement de Produits. She has 9 filings in total, and the 9 sampled filings run from 2022-01-06 to 2025-12-05. In this recent sample, the sell amount is EUR 73769, with filings relating to Exelixis, INC. and Mural Oncology plc.
